(Q42575942)

English

In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group

scientific article published on 15 December 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group (English)

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Acinetobacter baumannii

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Luis A Arroyo

1

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Ingeborg Mateos

2

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Verónica González

3

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Javier Aznar

4

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

language of work or name

0 references

publication date

15 December 2008

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

53

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

3

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

1295-1296

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Acinetobacter baumannii: emergence of a successful pathogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

28 May 2018

Tigecycline for the treatment of multidrug-resistant (including carbapenem-resistant) Acinetobacter infections: a review of the scientific evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

28 May 2018

Colistin heteroresistance in acinetobacter and its association with previous colistin therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

28 May 2018

In vitro activities of various antimicrobials alone and in combination with tigecycline against carbapenem-intermediate or -resistant Acinetobacter baumannii

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

28 May 2018

In vitro activity of tigecycline against multiple-drug-resistant, including pan-resistant, gram-negative and gram-positive clinical isolates from Greek hospitals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

28 May 2018

Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

28 May 2018

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

16 August 2018

Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

16 August 2018

In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

16 August 2018

Polymyxin-resistant Acinetobacter spp. isolates: what is next?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2650555

16 August 2018

Successful treatment of septic shock due to pan-resistant Acinetobacter baumannii using combined antimicrobial therapy including tigecycline

1 reference

https://pubmed.ncbi.nlm.nih.gov/19075049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/19075049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergy testing of multidrug resistant Acinetobacter baumanii against tigecycline and polymyxin using an E-test methodology

1 reference

https://pubmed.ncbi.nlm.nih.gov/19075049

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.01097-08

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

3 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42575942&oldid=2185177487"